Retroviral activation of interleukin 2 gene in a gibbon ape T cell lymphoma line by unknown
RETROVIRAL ACTIVATION OF INTERLEUKIN 2 GENE IN
A GIBBON APE T CELL LYMPHOMA LINE
BY DAVID B. DURAND,*4 MALEK KAMOUN,* CAROL A. NORRIS,*
NIKKI J . HOLBROOK,§ JUDITH S . GREENGARD,* GERALD R. CRABTREE,*
AND JEFFREY A. KANT*
From *The Department ofPathology and Laboratory Medicine, University ofPennsylvania,
Philadelphia, Pennsylvania 19104 ; *The Department ofPathology, Stanford University School
ofMedicine, Stanford, California 94306 ; and §The Laboratory ofPathology, National Cancer
Institute, National Institutes ofHealth, Bethesda, Maryland 20205
The MLA 144 cell line was derived from a lymphoma in a gibbon ape (1). At
the time of its establishment the line was found to be infected with a leukemia
virus (gibbon ape leukemia virus, San Francisco strain [GaLV SF]),' which is a C-
type retrovirus associated with a T cell lymphoma (1) . Although hybridization
studies (2, 3) indicate that human T cell leukemia/lymphoma (lymphotropic)
virus (HTLV) I and II are not closely related to any GaLV species they may
affect the same subset of genes involved withT lymphocyte growth . Specifically,
MLA 144 resembles the HTLV-infected cell lines MO and HUT-102 (3, 4) in
that it constitutively produces the T cell growth factor IL-2 (5)and IL-2 receptors
(6) . Although dual constitutive expression of IL-2 and IL-2R genesamong GaLV-
and HTLV-infected leukemias and lymphomas occurs sporadically (4, 5), in such
cases an autocrine mechanism may contribute to malignant cell growth (7) .
Recently, Chen et al . (8) established through Southern blotting that there are
rearrangements at the 5' and 3' ends of the IL-2 gene in MLA 144 cells . cDNA
cloning and sequencing showed that the 3' rearrangement is due to a GaLVSF
insertion in the 3' nontranslated region of one IL-2 allele . This insertion leads
to the production of a transcript ending in the viral long terminal repeat (LTR)
(8) . The complete structure ofthe 3' insertion and whether the 5' rearrangement
was also due to GaLV SF insertion remained unclarified . Also unanswered was
whether the two rearrangements involved the same IL-2 allele and whether both
alleles were transcriptionally active.The present study provides a complete struc-
tural characterization of both IL-2 alleles ofMLA 144 as well as a determination
of the relative transcriptional activity of the two alleles .
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Materials and Methods
MLA 144 Cosmid Library Construction and Screening.
￿
Cosmid clones were obtained by
a modification of the method of Ish-Horowicz and Burke (9). Briefly, high molecular
weight DNA was prepared from MLA 144, and subjected to RNase A treatment and
dialysis. Genomic fragments 30-45 kb in size were prepared by partial digestion with Sau
3A1. Vector arms were prepared by digesting equal quantities of pGcos4 DNA with Sst I
or Sal 1, respectively (10). The aliquots were mixed, treated with calf intestinal alkaline
phosphatase, and cut with Barn HI. The long vector arms were then isolated from a 1
agarose gel by the freeze-squeeze method (11). 1 lag of insert DNA was ligated to 2 lag of
arms in a 10-,ul reaction volume in the presence of 66 mM Tris, pH 7.5, 10 MM MgC12,
10 mM DTT, 1 mM ATP, and 100 lag/ml BSA for 3 h at 15°C. The ligated DNA was
packaged in vitro as described by the manufacturer (Gigapack; Vector Cloning Systems,
San Diego, CA), and used to transduce E. coli HB101 tested for recA negativity (12).
High-density screening on tetracycline plates (13) was carried out using a "P-labelled
human IL-2 cDNA probe (14). 454,000 colonies per microgram of insert DNA were
obtained, and of 150,000 colonies screened, 4 reacted strongly with the IL-2 cDNA
probe. Of these, three were recovered andmapped by means of single, double, and triple
restriction enzyme digests, as well as Southern blotting (15), as described in the text. DNA
probes were "P-labelled by the random primer method (16). The full-length GaLV probe
was a generous gift from M. Scott (17). The farthest 5' Eco RI fragment in clones 6.1,
7.1, and 8.1 wassubcloned from the cosmidsby usinga s2P-labelled probe made from the
300 by Eco RI-Pvu 11 fragment (Fig. 1A; map units 7.2-7.5 kb) obtained from the
overlapping Pvu 11 subclone.
Nucleotide Sequence of 5' GaLVSF Insertion.
￿
The Eco RI-Hind III restriction fragment
immediately upstream of the first IL-2 exon (map units 7.6-8.5 kb in the normal allele
[NL]; Fig. 1 A] was sequenced from both IL-2 alleles of MLA 144. Thesequencing strategy
forthe abnormal allele and the number of basepairs sequenced in a given direction were
as follows: Eco RI --* Pvu 11 (412), Sma I --+ Eco RI (368), Sma I --* Hind 111 (231), Pvu
11 --* Eco RI (342), Pvu 11 -* Hind III (231), and Hind III -+ Sma 1 (381). The normal
MLA IL-2 allele was sequenced from Hind III toward Eco RI (436 bp). The indicated
FIGURE 1 .
￿
(A) Restriction enzyme maps of the normal (NL) and doubly rearranged (AB)
MLA 144 IL-2 alleles. Mapping involved use of single, double, and triple restriction enzyme
digests and Southern blotting as described in the text. IL-2 regions were mapped with the
enzymes Cla I (C), Eco RI (E), Hind III (H), Pvu 11 (P), Sma I (S), and Xba I (X). Viral areas
were mapped with Eco RI, Hind III, Kpn I (K), Pst I (Ps), Pvu II, Sal I (Sl), and Sma I. The
transcriptional orientation of the IL-2 gene is 5' to 3' reading left to right. The putative
gibbon IL-2 exons are represented by solid blocks, whose placement is based on the close
homology between the normal human(14) andnormal gibbon IL-2 maps. The borders ofthe
retroviral insertions in the abnormal allele (AB) are indicated by broken lines between the
normal andabnormal allele maps. Amap of the GaLVSF unintegrated provirus is shown below
the abnormal allele map for comparison. The abnormal IL-2 allele contains a single LTR
insertion at the 5' end and a deleted provirus at the 3' end. Dotted lines connect the 5'
GaLVSF LTRto the 5' GaLV insertion in theabnormal allele. Thecrossing of thedotted lines
indicates the opposing transcriptional orientation of these LTRs. The 3' GaLV insertion
contains an internal deletion of 3.25 kb shown by the dotted lines. The region of the three
cosmid clones used to map the normal allele (C8.1) and the abnormal allele (C6.1 and C7.1)
are indicated by the solid linesabove and below the restriction maps. The double hatch mark
at the 3' end of the C6.1 clone indicates that the region 3' to this border did not contain
further viralsequence and most likely represented DNArecombined from some other part of
the MLA genome. (B) A schematic representation of the abnormal IL-2 allele in the gibbon
ape MLA 144 cell line. The probable locations of the four IL-2 exons, the fourth splitby the
3' retroviral insertion, areindicated by thesolidblocks. The retroviral LTRs areshown, with
therest of the 3' viral insertion appearingas a crosshatched bar. Arrows signify the transcrip-
tional orientation ofthe LTRs. Thetranscriptional orientation ofthe 5' inserted LTRopposes
that of the IL-2 gene.1726
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restriction fragments were gelpurified, cloned into the M13mp18 and M13mp19 vectors,
and sequenced by the chain-termination method (18, 19). Sequences were aligned by use
of the Bionet (IntelliGenetics, Mountain View, CA) programs.
RNA Preparation and Northern Blotting Analysis. Normal adult gibbon blood was
obtained from the Yerkes Regional PrimateResearch Center. Gibbon PBMC were isolated
by the Ficoll-Hypaque method as described (20). Gibbon PBMC were stimulated with
PHA-P (20,ug/ml) (Difco Laboratories,Detroit, MI) and PMA (10 ng/ml) (Sigma Chemical
Co., St. Louis, MO) for 18 h before harvest. MLA 144 cells were not stimulated. Jurkat
cells, which do not produce IL-2 constitutively (21), were stimulated with the same doses
of PHA and PMA for 6 h before harvest. RNA was extracted by the guanidinium
thiocyanate method (22), size fractionated (20 rig/lane) on 1.25% formaldehyde agarose
gels, transferred to nitrocellulose filters, and hybridized to a s2P-labelled human IL-2
cDNA probe (14, 23). The filters were washed four times for 5 min in 2 X SSC, 0.1%
SDS at 22°C followed by two 20-min washes in 0.1 X SSC, 0.1 % SDS at 65°C. The filters
were then dried and exposed to x-ray film for 2.5 d.
Results
Isolation and Characterization of Cosmid Clones Representing the Normal and
Doubly Rearranged IL-2 Alleles ofMLA 144. Previous Southern blots of Eco RI
digests of normal human (14) and normal gibbon DNA (8) hybridized to a full-
length "P-labelled human IL-2 genomic probe (pIL-2, which includes two 3,700
by Eco RI fragments containing all four human exons) revealed a band (actually
a doublet) at 3,700 bp. In contrast, the Southern blot of MLA 144 DNA revealed
a nonrearranged band at 3,700 bp, as well as bands at 4,500 and 6,000 bp, which
by use of 5'- and 3'-specific IL-2 probes were shown to represent 5' and 3'
rearrangements in the gene, respectively (8).
To characterize the structure of both IL-2 alleles of MLA 144 we made a
cosmid library from MLA 144 DNA and isolated three clones, 6.1, 7.1, and 8.1,
that hybridized to a "P-labelled human IL-2 cDNA probe (14). To map the
region containing IL-2 and viral sequences, we subcloned from each of the
cosmid clones the overlapping Eco RI and Pvu 11 fragments that hybridized to
"P-labelled pIL-2 and/or to a full length "P-labelled GaLV probe (pGaLV) (17).
The mapping results indicate that the Southern analysis of Eco RI digests of
MLA 144 DNA (described above) is explained by the presence of a normal allele
(NL, Fig. IA) represented by cosmid clone 8.1, and a doubly rearranged allele
(AB, Fig. 1A) represented by cosmid clones 6.1 and 7.1 . The normal allele
contributes the IL-2-hybridizing 3.7 kb Eco RI fragments seen on the MLA 144
genomic Southern blot, and the doubly rearranged allele contributes the 4.5 and
6.0 kb Eco RI fragments. A 3.8 kb Eco RI fragment at the 3' end ofthe abnormal
allele (described below in greater detail) comigrates with the 3.7 kb Eco RI
fragments of the normal allele . Like the normal human and gibbon IL-2 alleles,
cosmid 8.1 contains two 3.7 kb Eco RI fragments, which hybridize to pIL-2 but
not to pGaLV. The positions of restriction endonuclease sites. in the normal
gibbon allele show no significant differences from those in the two 3.7 kb Eco
RI fragments containing the four exons of the human IL-2 gene (14). For this
reason, the exons of the normal gibbon allele are likely to be located similarly to
those of the human gene, and are so indicated on the map (NL, Fig. 1A).
Cosmids6.1 and 7.1 representan IL-2 allele doubly rearranged by theinsertion
of GaLV sequences in two regions. Each contains Eco RI fragments of 4.2 andDURAND ET AL.
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5.1 kb that hybridize to pGaLV and to pIL-2; hence, the two rearranged Eco RI
bands seen in the MLA 144 Southern blot are from the same allele and are due
to insertions of retroviral sequences (solid lines on map AB, Fig. 1 A). Cosmid 7.1
has an additional 3.8 kb Eco RI fragment that hybridizes to pIL-2 and pGaLV
and contains the 3'-most portion of the IL-2 gene. Detailed mapping of clones
6.1 and 7.1 defined the sizes and locations ofthe 5' and 3' retroviral insertions,
as shown in Fig. 1 A. A small region of inserted GaLV sequence is found -1.3-
2.1 kb upstream ofthe first IL-2 exon, while a larger insertion (discussed below)
interrupts the fourth and final exon. In mapping the abnormal allele, it was
essential to establish the locations of the IL-2 sequences displaced by the inser-
tions. To do this we prepared probes from the Eco RI-Hind III fragments at
the 5' and 3' ends of human pIL-2, which are equivalent to the Eco RI-Hind
III fragments extending from 7.6 to 8.5 kb, and from 14.0 to 14.8 kb on the
map ofcosmid 8.1 (NL in Fig. 1 A). These probes hybridized to the Eco RI-Pvu
II fragments of cosmid 6.1 extending from 7.6 to 8.6 kb and 19.7 to 20.7 kb
(map AB ofFig. 1) overlapping the ends ofthe 5' and 3' insertions, respectively.
In short, this demonstrates that the Eco RI sites upstream ofthe 5' insertion and
downstream ofthe 3' insertion (Fig. 1 A) are notcontributedbyGaLVinsertions,
but instead represent displaced IL-2 sequences.
A comparison of the restriction map of the 3' GaLV insertions in clones 6.1
and 7.1 to a map of the unintegrated GaLV-SF provirus (Fig. IA) (17) indicates
that the 3' insertion in the abnormal allele is a provirus with a 3.25 kb internal
deletion sparing the two LTRs (Fig. 1 A). Such deletions have been observed in
many retroviral insertions (24). The LTRs in the 3' proviral insertion have the
same transcriptional orientation as the IL-2 gene. In contrast, the map ofthe 5'
insertion in the abnormal allele suggests that these inserted GaLV sequences
represent a single LTR with a transcriptional orientation opposing that of the
IL-2 gene. Sequence data presented below confirm this impression. A schematic
diagram ofthe abnormal allele is presented in Fig. 1 B.
Sequencing of Normal and Abnormal Alleles in the Region of the 5' GaLV Inser-
tion. To substantiate our conclusions regarding the 5' insertion, we sequenced
the Eco RI-Hind III fragment immediately upstream of the first IL-2 exon in
both normal and abnormal gibbon IL-2 alleles (Fig. 2). The only discrepancies
between the LTR sequence of the 5' insertion and the previously published
partial LTR sequences of the 3' insertion (8) were the absence of bases in the
latter sequence found at positions 727, 850, 918, 920, 1,023, and 1,025 ofour
sequence. The last four discrepancies represent a pair ofbase changes in a direct
repeat. Acompression ofthe bands corresponding to this region (CCCTGGCC)
on sequencing gels precluded precise reading of this sequence, despite analysis
of both strands of DNA. The 5' insertion is an LTR without additional viral
sequences represented. Similar single LTR insertions have been described (25-
27). A 3 by duplication ofhost DNA is seen at the borders ofthe 5' intergration,
similar to the duplications noted for a variety of other retroviruses (24). There
is a 96 by direct repeat in the U3 region of the 5' insertion nearly identical to
the 94 by repeat in the 5' LTR of the 3' insertion (8). Of interest was whether
the same direct repeat waspresent in the previously cloned unintegrated GaLVSF
provirus (Fig. 1 A), since the published sequence does not contain this repeat172 8
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Sequences of the GaLVsr LTR (V) (32) and of the normal (NL) and abnormal
(AB) MLA 144 IL-2 alleles in the region of the 5' GaLVSF insertion. Vertical bars connect
homologous bases. The alignment of the 5' end of the LTRs at positions 1,150-1,156 was
made, since the sequence TCTTTCA is in one of the viral inverted terminal repeats. The
poor alignment from 1,071 to 1,096 may be due to an inversion of the two underlined se-DURAND ET AL.
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(17). On a 2% agarose gel, the three Pst I-Sma I fragments of the LTRs in the
5' and 3' insertions all comigrate at ^"420 bp, whereas the two Pst I-Sma I LTR
fragments in the GaLVSF clones comigrate at ^-320 bp. Comparison of the
inserted and unintegrated proviral sequences makes it clear that the observed
size difference is most likely due to the presence of the direct repeat in the
integrated LTR and the absence ofthe direct repeat in the unintegrated proviral
LTRs. The commonly observed sequencing error of missing direct repeats is
therefore excluded, and all three LTRs in the abnormal IL-2 allele of MLA 144
are likely to contain a 96 by direct repeat.
Further analysis of the sequence upstream from the 5' GaLVSF LTR insertion
reveals a set o£sequences associated with functional genes, including a CAT box
(CAAT) separated from a TATA box (TATAAA) by 35 bp, in turn followed by
a potential cap site (AGT) and a potential translation initiation site (ATG) (Fig.
2). These elements are in a transcriptional orientation opposing that ofthe IL-2
gene . In short, there may be a gene or pseudogene adjacent to the IL-2 gene.
The potential implications of this finding are discussed below. As yet we have
discovered no significant homology ofthis sequence to published sequences, and
we have begun Northern analysis to determine whether the gene is expressed in
MLA or in other tissues.
Northern Analysis of MLA 144, Normal Gibbon, and Human IL-2 Message.
￿
To
support the notion that one or both retroviral insertions have activated the IL-2
gene in MLA 144, we performed Northern analysis on total RNA extracted
from mitogen-stimulated normal gibbon PBMC and unstimulated MLA cells
(Fig. 3). RNA derived from the human T cell line Jurkat (21), which can be
induced to express large quantities of IL-2 mRNA (28, 29), provided a control.
TheJurkat IL-2 mRNA is identical in size (900 bp) to that produced by normal
human T cells (28, 29). We found that the predominant MLA 144 mRNA
hybridizing to a 32P-labelled human IL-2 cDNA probe was ^-1,125 by long, 225
by longer than the IL-2 messages ofJurkat and ofPBMC from two normal adult
gibbons. When gibbon and MLA 144 RNA samples were mixed and electropho-
resed in the same lane, the distribution ofhybridizing RNA was the sum of the
bands observed when the RNAs were electrophoresed in separate lanes (data not
shown); this demonstration excludes a salt concentration effect as an explanation
for the difference in migration of the MLA 144 IL-2 message. We conclude that
the larger size ofthe mRNA species produced constitutively by MLA 144 reflects
the fact that the GaLV insertion in the fourth exon of the altered IL-2 gene
interrupts the 3' nontranslatedregion ofthe transcript (8), and that the abnormal
allele has been activated by one or both GaLV insertions.
quences. Putative U5-R and R-U3 GaLVSF bordersbasedon homology to simian sarcomavirus
(33) as well as theviralCAT box, TATA box, andpolyadenylation(PolyA) signal areindicated.
The direct repeat in the U3 region of the 5' insertion is underlined (positions 853-1,053).
The CAT box, TATA box, a potential cap site (AGT), and a potential translation initiation
site (ATG) of the putative gene upstream from the 5' LTR insertion lie between positions 9
and 343 in the sequence. Transcriptional orientations are indicated by arrows.1730
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FIGURE 3 .
￿
Northern analysis of normal gibbon, MLA, andJurkat RNAs . A Northern blot
of total cellular RNA from the PBMC of two normal gibbons (lanes 1 and 2), MLA cells (lane
3), and Jurkat cells (lane 4) is shown . Gibbon PBMC were isolated by the Ficoll-Hypaque
method andwere then stimulated with PHA-P (1 :500 final dilution)and PMA (10ng/ml) for
18 h before harvest . Jurkat cells were stimulated with the same doses ofPHA and PMA for 6
h before harvest, while MLA 144 cells were not stimulated . RNA was extracted by the
guanidinium thiocyanate method, size fractionated (20 jug/lane) on 1 .25% formalde-
hyde/agarose gels, transferred to nitrocellulose filters, andhybridized to a "P-labelled human
IL-2 cDNA probe . Filters were then washed four times for 5 min in 2 X SSC, 0.1% SDS at
22 °C followed by two20-min washes in 0.1 XSSC, 0.1% SDS at 65'C . Filters were then dried
andexposed to x-ray film for 2.5 d .
Discussion
Our studies demonstrate that the MLA 144 cell line has a normal IL-2 allele
and a doubly rearranged IL-2 allele with retroviral insertions at its 5' and 3'
ends . Since the vast majority of transcripts are from the abnormal allele, one or
both retroviral insertions are likely to be responsible for constitutive expression
of the allele . Several possible mechanisms could explain the activation of the
abnormal allele . Since the transcriptional orientation of the 5' LTR insertion is
opposite that of the IL-2 gene, transcription initiated by a viral promoter and
extending into the IL-2 gene is unlikely to occur . Nevertheless, there may be a
second promoter present in the LTR with an orientation opposite that of the
major LTR promoter, as previously shown (30) for the activation of the c-mos
oncogene by an intracisternal A particle (an endogenous retrovirus) insertion .
In this example, both viral and host promoters initiated transcripts containing c-
mos (30) . Preliminary S1 mapping studies indicate that the transcriptional start
site of IL-2 message in MLA 144 is identical to that of normal human IL-2
message (data not shown) ; hence, involvement ofa viral promoter in IL-2 gene
transcription is unlikely .DURAND ET AL.
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Still other mechanisms are possible. By analogy to the c-myc oncogene, where
it was found that avian leukosis virus insertions either 5' or 3' to c-myc in either
orientation can activate its expression (31, 32), either of the GaLV insertions
maycontribute to activation of thealtered IL-2 allele in MLA 144 by an enhancer
mechanism, perhaps mediated by the 96 by direct repeat. Recent studies indicate
that the inserted LTRs have enhancer activity when linked to the SV40 early
region promoter (N . Holbrook, A. Gulino, D. Durand, Y. Lin, and G. Crabtree,
manuscript in preparation). Similar duplicated sequences have been observed in
the U3 regions of a number of RNA and DNA tumor viruses, including
GaLVSEATO (33), the Moloney murine sarcoma virus (34), and SV40 (35-37), the
latter two with proven transcriptional enhancer function . Of note is the fact that
GaLVSEATO contains a direct repeat of 45 by located within the 96 by subunit
(33). If the repeats in the MLA 144 LTR insertions are represented by ABC-
ABC, then the corresponding region in GaLV111TO is represented by AB-BC. (A
refers to by 1,020-1,053 B to by 970-1,019, and C to by 953-969 in Fig. 2.)
This means that GaLVSEATO may have evolved either from GaLVSF or from a
common ancestral species by the deletion of a portion of the 96 by direct repeat.
Alternatively, the direct repeats in the LTRs of the MLA 144 insertions and
those in the GaLVSEATo LTRs may have resulted from independent duplication
events.
The 3' GaLV insertion might lead to constitutive IL-2 expression, either alone
or in concert with an enhancer effect, by a different mechanism. The 3' insertion
results in deletion of normal IL-2 3' nontranslated sequence from the transcript,
as well as inclusion of viral information in (8) and lengthening of the transcript,
which might increase IL-2 mRNA stability and contribute toward increased
expression of the abnormal IL-2 allele (38).
Recently (39) it was found that the murine cell line WEHI-3B, which consti-
tutively produces IL-3, has an intracisternal A particle insertion 5' to its IL-3
gene. As discussed by the authors, IL-3 is a potential growth factor for this line
(39). MLA 144 represents the first primate example of growth factor gene
activation due to retroviral insertion and the first example of growth factor gene
activation by the insertion of an infectious retrovirus.
Beyond the question of how the abnormal allele is activated, the true cause of
the MLA 144 malignancy remains unknown. Clearly, the constitutiv% expression
of IL-2 could have been selected for either in tissue culture or in the host;
however, the original tissue specimen is not available to allow examination of
this question (T. Kawakami, personal communication). Regardless of the milieu
in which it occurred, the second retroviral insertion in the abnormal allele may
have been selected for due to its ability to confer a growth advantage on the cell
line by further enhancing the activation of IL-2 gene.
Smith (40) derived sublines of MLA 144 whose constitutive expression of IL-
2 wasapparently abolishedby glucocorticoids. The proliferation of these sublines
was also substantially reduced though not obliterated by glucocorticoids, an
effect reversed by the addition of exogenous IL-2; hence, MLA 144's growth is
in part IL-2 dependent and in part IL-2 independent (40) . These results imply
that, while constitutive IL-2 gene expression may augment the proliferation of
MLA 144, other factors must play a role in the cell line's growth. Gene products1732
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other than IL-2 may be implicated, since there are multiple retroviral insertions
in the MLA 144 genome (8), and the putative gene upstream of the IL-2 gene
may have been activated by the 5' GaLV insertion. If a second independent
oncogenic event of this kind is implicated in MLA 144's growth, then the IL-2
autocrine mechanism may represent one of two "hits" (41) required to produce
this T cell malignancy. Alternatively, the autocrine mechanism may have been
selected for after the oncogenic event(s) occurred .
Summary
The gibbon ape leukemia virus (GaLVs,)-infected T cell line, MLA 144, was
established from the lymphoma of a gibbon ape (1). The cell line constitutively
expresses IL-2 (5) and its receptor (6), implying that an autocrine mechanism
could be responsible for or contribute toward its growth.
To explore the mechanism of constitutive IL-2 expression in MLA 144, we
have isolated and characterized cosmid clones representing a normal and a
doubly inserted IL-2 allele in this cell line. The map of the normal MLA 144
IL-2 allele closely resembles that of the normal human IL-2 gene . The abnormal
allele contains a 3' insertion that is a GaLV,, provirus with two long terminal
repeats (LTR) and an internal 3.25 kb deletion. At the 5' end of the abnormal
allele is a second insertion that DNA sequencing showed to be an isolated GaLVSF
LTR with a transcriptional orientation opposing that of the IL-2 gene. We
demonstrate by Northern blotting analysis that the vast majority of transcripts
are from the abnormal allele, implying that one or both retroviral insertions are
responsible for constitutive expression of the allele.
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